Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-31 @ 1:04 AM
Study NCT ID:
NCT01832467
Status:
COMPLETED
Last Update Posted:
2020-06-18
First Post:
2013-04-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cetuximab Rechallenge Study
Sponsor:
Chinese University of Hong Kong
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04-24
Start Date Type:
None
Primary Completion Date:
2020-04-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-04-07
Completion Date Type:
ACTUAL
First Submit Date:
2013-04-10
First Submit QC Date:
None
Study First Post Date:
2013-04-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-06-17
Last Update Post Date:
2020-06-18
Last Update Post Date Type:
ACTUAL